Putnam Investments’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,841,590
| Closed | -$7.55M | – | 1255 |
|
|
2022
Q1 | $7.55M | Buy |
1,841,590
+63,313
| +4% | +$230K | 0.01% | 406 |
|
|
2021
Q4 | $6.35M | Buy |
1,778,277
+26,126
| +1% | +$91.4K | 0.01% | 475 |
|
|
2021
Q3 | $6.38M | Buy |
1,752,151
+25,529
| +1% | +$103K | 0.01% | 465 |
|
|
2021
Q2 | $7.53M | Buy |
1,726,622
+5,095
| +0.3% | +$20.8K | 0.01% | 435 |
|
|
2021
Q1 | $7.08M | Buy |
1,721,527
+922,400
| +115% | +$4M | 0.01% | 440 |
|
|
2020
Q4 | $3.19M | Sell |
799,127
-5,427
| -0.7% | -$17.6K | 0.01% | 568 |
|
|
2020
Q3 | $2.17M | Hold |
804,554
| – | – | ﹤0.01% | 633 |
|
|
2020
Q2 | $2.21M | Buy |
804,554
+186,374
| +30% | +$520K | ﹤0.01% | 655 |
|
|
2020
Q1 | $1.46M | Sell |
618,180
-1,630
| -0.3% | -$5.54K | ﹤0.01% | 676 |
|
|
2019
Q4 | $2.91M | Buy |
619,810
+47,880
| +8% | +$196K | 0.01% | 665 |
|
|
2019
Q3 | $1.91M | Buy |
571,930
+1,368
| +0.2% | +$4.5K | ﹤0.01% | 724 |
|
|
2019
Q2 | $1.88M | Buy |
570,562
+1,449
| +0.3% | +$4.19K | ﹤0.01% | 727 |
|
|
2019
Q1 | $1.72M | Buy |
+569,113
| New | +$1.84M | ﹤0.01% | 716 |
|
|
2015
Q4 | – | Sell |
-722,500
| Closed | -$1.23M | – | 1511 |
|
|
2015
Q3 | $1.23M | Hold |
722,500
| – | – | ﹤0.01% | 1118 |
|
|
2015
Q2 | $1.5M | Hold |
722,500
| – | – | ﹤0.01% | 1132 |
|
|
2015
Q1 | $1.96M | Hold |
722,500
| – | – | ﹤0.01% | 1060 |
|
|
2014
Q4 | $1.86M | Sell |
722,500
-6,695
| -0.9% | -$15K | ﹤0.01% | 1046 |
|
|
2014
Q3 | $1.33M | Sell |
729,195
-343,316
| -32% | -$748K | ﹤0.01% | 1139 |
|
|
2014
Q2 | $2.86M | Buy |
1,072,511
+372
| +0% | +$1.12K | 0.01% | 944 |
|
|
2014
Q1 | $3.75M | Buy |
1,072,139
+587,044
| +121% | +$2.6M | 0.01% | 869 |
|
|
2013
Q4 | $2.17M | Buy |
+485,095
| New | +$1.98M | 0.01% | 1022 |
|
Other funds holding ATRS
Putnam Investments's ATRS Position: Q2 2022 in Review
Putnam Investments sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,841,590 shares — an estimated $7.55M sold.
Putnam Investments first reported a position in ATRS in Q4 2013 and held it in 21 quarters. The position peaked at $7.55M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Putnam Investments reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Putnam Investments sold 1,841,590 Antares Pharma, Inc. shares in Q2 2022, an estimated $7.55M.
- Putnam Investments first reported a position in Antares Pharma, Inc. in Q4 2013 and held it in 21 quarters.
- Putnam Investments's Antares Pharma, Inc. position peaked at $7.55M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.